- /
- Supported exchanges
- / US
- / AVLN.NASDAQ
Avalyn Pharma Inc. Common Stock (AVLN NASDAQ) stock market data APIs
Avalyn Pharma Inc. Common Stock Financial Data Overview
Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis; and AP03, a fixed-dose combination of inhaled pirfenidone and nintedanib to deliver dual antifibrotic mechanisms. Avalyn Pharma Inc. was formerly known as Genoa Pharmaceuticals, Inc. and changed its name to Avalyn Pharma Inc. in July 2017. The company was incorporated in 2011 and is based in Boston, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Avalyn Pharma Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Avalyn Pharma Inc. Common Stock data using free add-ons & libraries
Get Avalyn Pharma Inc. Common Stock Fundamental Data
Avalyn Pharma Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -109 802 000
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Avalyn Pharma Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-08-12
- EPS/Forecast: -1.03
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Avalyn Pharma Inc. Common Stock News
New
Biotech Stocks At 52-Week Highs - HALO +20% On Q2 Results, FENC, AVLN, AMLX, CHE
(RTTNews) - The following biotech stocks reached 52-week highs on August 7, 2026, driven by key catalysts such as positive quarterly reports or upcoming clinical results. Halozyme Therapeutics Inc. (...
Catalyst Watch: Fedspeak ramps up post-Powell, core PCE, and box office blitz
[Business Stock Exchange Trading Concepts] Rawpixel Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that ma...
Avalyn Pharma Surges 44% After $300 Million Upsized IPO
This article first appeared on GuruFocus. Avalyn Pharma delivered a sharp first-day move in its Nasdaq debut, with shares jumping 44% after the biopharmaceutical company raised $300 million in an ups...
Avalyn Pharma prices $300M IPO at $18 per share
[IPO Concept with Stock Market Graphs] AlexSecret * Clinical-stage biopharmaceutical company Avalyn Pharma (AVLN [https://seekingalpha.com/symbol/AVLN]) priced [https://seekingalpha.com/pr/20493899...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.